XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Stock-based Compensation
3 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6.
      Stock-based Compensation
 
We recognize compensation expense for stock-based payment awards made to our employees and directors, including stock options and restricted shares under our
2007
Long Term Incentive Plan, as amended (the
“2007
Incentive Plan”) and our Directors’ Restricted Stock Plan. During the
three
-months ended
March
31,
2017
and
2016
our stock-based compensation expense included only expenses associated with our
2007
Long Term Incentive Plan. The following table provides our stock-based compensation expense and related income tax benefit for the
three
-month periods ended
March
31,
2017
and
2016
(in thousands).
 
 
 
Three Months Ended March 31,
 
 
 
2017
 
 
2016
 
Stock-based compensation expense, gross
  $
1,337
    $
1,284
 
Income tax benefit at our statutory rate associated
with stock-based compensation
   
(521
)    
(501
)
Stock-based compensation expense, net
  $
816
    $
783
 
 
2007
Long
T
erm Incentive Plan
 
The
2007
Incentive Plan provides for the grant of incentive stock options, nonqualified stock options, restricted stock awards, stock appreciation rights, and performance awards to acquire shares of our Class A common stock or common stock, or the receipt of other awards based on our performance, to our employees and non-employee directors.
 
During the
three
-month period ended
March
31,
2017,
we granted:
 
 
307,943
shares of restricted common stock to certain employees, of which
102,648
shares will vest on each of
January
31,
2018
and
2019;
and
102,647
shares will vest on
January
31,
2020.
 
198,220
shares of restricted Class A common stock to an employee, of which
66,073
shares will vest on each of
January
31,
2018
and
2019
and
66,074
shares will vest on
January
31,
2020.
 
During the
three
-month period ended
March
31,
2016,
we granted:
 
 
218,452
shares of restricted common stock to certain employees, of which
72,816
shares vested on
January
31,
2017;
72,816
shares will vest on
January
31,
2018;
and
72,820
shares will vest on
January
31,
2019.
 
166,677
shares of restricted Class A common stock to an employee, of which
55,559
shares vested on
January
31,
2017
and
55,559
shares will vest on each of
January
31,
2018
and
2019.
 
19,048
shares of restricted common stock and
51,935
shares of restricted Class A common stock to certain non-employee directors, all of which vested on
January
31,
2017.
 
A summary of restricted common stock and Class A common stock activities for the
three
-month periods ended
March
31,
2017
and
2016
is as follows:
 
 
 
Three Months Ended
 
 
 
March 31, 2017
 
 
March 31, 2016
 
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
Average
 
 
 
Number
 
 
Grant Date
 
 
Number
 
 
Grant Date
 
 
 
of
 
 
Fair Value
 
 
of
 
 
Fair Value
 
 
 
Shares
 
 
Per Share
 
 
Shares
 
 
Per Share
 
Restricted common stock:
                               
Outstanding - beginning of period
   
396,033
    $
12.06
     
337,506
    $
9.57
 
Granted
   
307,943
    $
10.40
     
237,500
    $
12.88
 
Vested
   
(200,291
)   $
11.82
     
(178,973
)   $
8.46
 
Outstanding - end of period
   
503,685
    $
11.14
     
396,033
    $
12.06
 
                                 
Restricted Class A common stock:
                               
Outstanding - beginning of period
   
415,082
    $
10.15
     
374,693
    $
9.46
 
Granted
   
198,220
    $
10.60
     
218,612
    $
11.25
 
Vested
   
(227,526
)   $
10.00
     
(178,223
)   $
10.04
 
Outstanding - end of period
   
385,776
    $
10.47
     
415,082
    $
10.15
 
 
At
March
31,
2017
and
December
31,
2016,
we had
274,746
options to acquire our common stock outstanding, all of which were vested and exercisable. The exercise price of all outstanding stock options is
$1.99
per share. As of
March
31,
2017
and
December
31,
2016,
we did not have any options outstanding for our Class A common stock. The aggregate intrinsic value of our outstanding stock options was
$3.4
million based on the closing market price of our common stock on
March
31,
2017.